APA

Schilter H., Findlay A. D., Perryman L., Yow T. T., Moses J., Zahoor A., Turner C. I., Deodhar M., Foot J. S., Zhou W., Greco A., Joshi A., Rayner B., Townsend S., Buson A. & Jarolimek W. (20200721). The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis. : Journal of cellular and molecular medicine.

Chicago

Schilter Heidi, Findlay Alison D, Perryman Lara, Yow Tin T, Moses Joshua, Zahoor Amna, Turner Craig I, Deodhar Mandar, Foot Jonathan S, Zhou Wenbin, Greco Angelique, Joshi Amar, Rayner Benjamin, Townsend Sarah, Buson Alberto and Jarolimek Wolfgang. 20200721. The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis. : Journal of cellular and molecular medicine.

Harvard

Schilter H., Findlay A. D., Perryman L., Yow T. T., Moses J., Zahoor A., Turner C. I., Deodhar M., Foot J. S., Zhou W., Greco A., Joshi A., Rayner B., Townsend S., Buson A. and Jarolimek W. (20200721). The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis. : Journal of cellular and molecular medicine.

MLA

Schilter Heidi, Findlay Alison D, Perryman Lara, Yow Tin T, Moses Joshua, Zahoor Amna, Turner Craig I, Deodhar Mandar, Foot Jonathan S, Zhou Wenbin, Greco Angelique, Joshi Amar, Rayner Benjamin, Townsend Sarah, Buson Alberto and Jarolimek Wolfgang. The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis. : Journal of cellular and molecular medicine. 20200721.